Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05696002

Advanced Pelvic Surgical Oncology Database - Prospective Observational Study

Retrospective and prospective observational study of patients undergoing advanced pelvic oncological resection for maligancy including multi visceral resection, beyond TME resection and sacrectomy/flap reconstruction/urinary reconstruction at Glasgow Royal Infirmary.

Goal is to study and report outcomes for patients to characterise and understand major complications, natural history of resectional patients and identify areas for future interventional study.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Rectal Cancer Colon Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Gynecologic Cancer Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Pelvic Cancer Pelvic Neoplasms Rectal Diseases Rectal Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

Academic Department of Surgery, Glasgow Royal Infirmary

Glasgow, United Kingdom

Location status: Recruiting

Location contact

Norman Galbraith, MSc PhD MRCS

CONTACT

07449784948

Norman Galbraith, PhD MRCS

PRINCIPAL_INVESTIGATOR

About this study

Retrospective and prospective observational study of patients undergoing advanced pelvic oncological resection for maligancy including multi visceral resection, beyond TME resection and sacrectomy/flap reconstruction/urinary reconstruction at Glasgow Royal Infirmary.

Goal is to study and report outcomes for patients to characterise and understand major complications, natural history of resectional patients and identify areas for future interventional study..

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Advanced pelvic oncological resection defined as more than 1 pelvic organ resected

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Cancer-specific survival

    Time frame: 10 years

    Months

  2. Overall survival

    Time frame: 10 years

    Months

  3. Post-operative complications

    Time frame: 10 years

    Frequency

  4. Quality of life (survey)

    Time frame: 10 years

    Score

Study contacts

Contact information is provided by the study sponsor or research team.

Colin Steele, PhD FRCS

CONTACT

[email protected]

07449784948

Norman Galbraith, PhD MRCS

CONTACT

[email protected]

07449784948

Sponsors and collaborators

Lead sponsor

Glasgow Royal Infirmary

Other

Registry information

Important dates

Study start
2023
Primary completion
2028
Study completion
2030
First posted
Jan 25, 2023
Registry last updated
Jan 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.